Skip to main content
Scienza Health
Compliance

F-Tag 605 Documentation That Survives a Survey

David Kaiser, Founder & CEO··Updated October 2026·4 min read
Share

Surveyors read the record, not the intent; the chart has to show the monitoring, the clinician's decision and the follow-up, in that order..

Last updated: October 2026

Surveyors read the record, not the intent; the chart has to show the monitoring, the clinician's decision and the follow-up, in that order.

What does F-Tag 605 documentation need to show?

It needs to show that the resident on a psychotropic medication was monitored on a schedule, that a clinician reviewed what the monitoring found and made a decision, and that the follow-up happened. A surveyor should be able to read the chart and reconstruct the sequence without asking anyone.

F-Tag 605 covers the resident's right to be free from chemical restraints and the facility's duties around psychotropic medication: an indication in the record, monitoring, and gradual dose reduction attempts unless clinically contraindicated.

Most citations are not about the medication. They are about the record.

The cost of a citation is not the plan of correction. It is the resurvey, the staff time to prepare for it and the public record of the deficiency. The record that survives a survey is cheaper than the record that is rebuilt after one.

What surveyors look for

An indication documented for every psychotropic. Behavior and effect monitoring at a cadence, with dates and names. Evidence that a clinician looked at the monitoring and decided something, including whether to attempt a dose reduction. Evidence the decision was carried out.

The surveyor is reconstructing a sequence. Every gap in it is a finding.

They also look for the resident's voice. Was the resident or the representative told about the medication and the plan to reduce it? Is there a record of what the resident said about how they feel? A monitoring record that is all observation and no conversation is thinner than it looks.

Where the documentation fails

Monitoring that happened but lives in a nurse's memory. Monitoring that is charted but never reviewed. A clinician's review with no recorded decision. A decision with no follow-up date. A follow-up date that passed without a note.

None of these is a care failure. All of them are survey findings.

Cadence failures are the most common. The care plan says weekly. The chart shows three entries in two months. The surveyor does not need to ask why; the gap is the finding.

Attribution is the second most common. An entry with a time and no name, or a name and no credential, is an entry the surveyor cannot count. The record has to say who observed, who reviewed and who decided, as three different people when they were.

A check-in cadence the chart can show

Gia calls the resident on the schedule the facility sets, by phone or video, in the resident's language. A short conversation about sleep, mood, appetite and the day. A 40-second speech check-in inside the call. If the resident does not answer, Gia retries, and the missed attempt is recorded too.

Each check-in is a dated, attributed entry. The cadence is visible on the chart, not in a binder.

Caregiver check-ins add the family's account. What a son noticed on Sunday about his mother's mood or sleep sits beside what she said on Monday. The record shows that the facility asked.

Structured assessments in the record

When a clinician clicks Initiate Assessment, Gia administers the BIMS, a cognitive screening, or an ADL and IADL review in conversation. Results reach the clinician in under two minutes.

After review, the scored assessment writes back to PointClickCare, Epic or your EHR, in the window it was administered. The surveyor finds it where the regulation expects it.

The clinician can repeat an assessment. If a resident sounded different or a score moved, one click sends Gia back the next day. Both results sit in the chart with their dates. The surveyor sees that someone noticed and followed up.

The clinician's decision, recorded

Every result arrives with Proactive Decision Actions. Options, never orders. The clinician picks one, adds a note and assigns the follow-up with a date. That is the decision the surveyor is looking for, in the clinician's name.

A check-in is a screening conversation. Gia is clinical decision support, not a diagnosis. Gia changes no medication and places no orders. The pharmacist, the prescriber and the DON decide. The chart shows that they did.

Pull one chart and read it as a surveyor. Indication, monitoring at cadence, review with a decision, follow-up on the date promised. If every link is there, in order, with a name on it, the record survives. If a link is missing, you have found the finding before the surveyor did.

Where to start

Pull the charts of every resident on a psychotropic medication and try to reconstruct the monitoring, decision and follow-up sequence from the record alone. Where you cannot, that is the unit to start on.

See how post-acute and senior living operators use Gia for F-Tag 605 documentation, then book a working session with your DON and compliance officer.

Sources & References

  1. eCFR, 42 CFR 483.12 Freedom from abuse, neglect, and exploitation (F-Tag 605 scope): https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-G/part-483/subpart-B/section-483.12
  2. eCFR, 42 CFR 483.45 Pharmacy services (psychotropic medication requirements): https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-G/part-483/subpart-B/section-483.45
DK
David KaiserFounder & CEO

David Kaiser is the Founder and CEO of Scienza Health, the company behind Gia, an AI co-clinician that health plans, ACOs, health systems and senior-care operators use to check in with older adults between visits.

This content is intended for informational purposes and does not constitute medical advice. Citing research does not mean this page or the product has been independently peer reviewed.

Share

See Gia work on your population.

Predictive medicine, from home care to health systems.

Book a demo